中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
11期
88-89
,共2页
中药%川芎嗪%乙型脑炎
中藥%川芎嗪%乙型腦炎
중약%천궁진%을형뇌염
TCM%Ligustrazine%Encephalitis B
目的：探讨中药川芎嗪注射液治疗乙型脑炎的临床疗效。方法：将60例乙型脑炎患者随机分为实验组30例和对照组30例，实验组除采用常规的综合治疗外，加用中药川芎嗪注射液，对照组则采用常规综合治疗。结果：治疗结束后，实验组的总有效率达到96.7%，对照组的总有效率为73.3%，实验组的治疗效果显著优于对照组（P<0.05），且未见有明显的药物不良反应。结论：中药川芎嗪注射液在治疗乙型脑炎方面具有明显的疗效，而且安全无不良反应，可以在临床上应用推广。
目的：探討中藥川芎嗪註射液治療乙型腦炎的臨床療效。方法：將60例乙型腦炎患者隨機分為實驗組30例和對照組30例，實驗組除採用常規的綜閤治療外，加用中藥川芎嗪註射液，對照組則採用常規綜閤治療。結果：治療結束後，實驗組的總有效率達到96.7%，對照組的總有效率為73.3%，實驗組的治療效果顯著優于對照組（P<0.05），且未見有明顯的藥物不良反應。結論：中藥川芎嗪註射液在治療乙型腦炎方麵具有明顯的療效，而且安全無不良反應，可以在臨床上應用推廣。
목적：탐토중약천궁진주사액치료을형뇌염적림상료효。방법：장60례을형뇌염환자수궤분위실험조30례화대조조30례，실험조제채용상규적종합치료외，가용중약천궁진주사액，대조조칙채용상규종합치료。결과：치료결속후，실험조적총유효솔체도96.7%，대조조적총유효솔위73.3%，실험조적치료효과현저우우대조조（P<0.05），차미견유명현적약물불량반응。결론：중약천궁진주사액재치료을형뇌염방면구유명현적료효，이차안전무불량반응，가이재림상상응용추엄。
Objective: To discuss clinical efficacy of ligustrazine on encephalitis B. Methods: 60 cases of encephalitis B were randomly divided into the experimental group and control group, 30 cases for each. The control group was given synthetically conventional therapy; the experimental group was given ligustrazine injection more. Results: After treatment, the total efficiency in the experimental group was 96.7%, the control group was 73.3%. Efficacy in the experimental group significantly was better than the control group (P<0.05). No adverse reactions. Conclusion: There was an obvious efficacy of ligustrazine injection on encephalitis B, no adverse reactions. Clinical applications could were spreaded.
